(Q51978234)

English

Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

author name string

Tamison Doey

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Kenneth Handelman

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Jamie A Seabrook

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Margaret Steele

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Canadian Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

52

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

363-368

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Pharmacotherapy of first-episode psychosis

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Antipsychotics in clinical practice: guidelines for safe and effective use.

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Separation anxiety in children and adolescents treated with risperidone

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

The treatment of Tourette's syndrome: current opinions

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Bipolar disorder in children and adolescents: current challenges.

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Psychopharmacologic treatment of pathologic aggression

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Can diabetes mellitus be induced by medication?

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Hyperglycemia and hypertriglyceridemia secondary to olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Olanzapine and hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Triglyceride, cholesterol and weight changes among risperidone-treated youths. A retrospective study

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Risperidone in children with autism and serious behavioral problems

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

A placebo-controlled trial of risperidone in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Novel antipsychotics and severe hyperlipidemia

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Atypical antipsychotic induced weight gain: pathophysiology and management

1 reference

https://api.crossref.org/works/10.1177%2F070674370705200605

21 January 2018

Identifiers

10.1177/070674370705200605

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17696022

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51978234&oldid=2102061736"